Formulation of Tablets – PST06103 Pharmaceutical Production

NTA Level 6 • Semester 1 • PST06103

Formulation of Tablets

Pharmaceutical Production • Source Session/Topic 16
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 16: Formulation of Tablets

Total Session Time: 120 minutes

Pre-requisites

• None

Learning Tasks

By the end of this session students are expected to be able to:

• Define formulation
• Explain main ingredients used in tablet production
• Classify excipients used in tablet production
• List characteristics of excipients used in tablet production
• Explain role of excipients used in tablet production

Resources Needed:

• Flip charts, marker pens, and masking tape
• Black/white board and chalk/whiteboard markers
• LCD projector and computer

SESSION OVERVIEW

|Step |Time |Activity/ |Content |

| | |Method | |

|1 |05 minutes|Presentation |Introduction, Learning Tasks |

|2 |30 minutes|Presentation |Formulation of Tablets |

|3 |25 minutes|Buzzing |Ingredients used in Tablet Production |

| | |Presentation | |

|4 |50 minutes|Presentation |Classification, Properties and Roles of |

| | | |Excipients |

|5 |05 minutes|Presentation |Key Points |

|6 |05 minutes|Presentation |Evaluation |

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing

STEP 1: Formulation of Tablets (30 minutes)

• Tablet formulation is the process in which the active pharmaceutical

ingredient(s) (APIs) and excipients are combined to produce a tablet

o The type and amounts of each ingredient i.e. the medicament(s) and the

excipients are known prior to manufacturing process

o Formulation must ensure that the dosage form formed is stable

acceptable to the patient who will use it

o In formulation the variety of ingredients used (including the drug

itself) must be compatible with each other

o Therefore it is very important to do a lot of formulation studies in

order to detect the point of compatibility

o Formulation studies must focus on other factors like particle size,

polymorphism, pH and solubility, in order to check whether these

factors will effect on bioavailability of the drug or not

o Oral formulations such as tablets and capsules must be formulated in

such as way to ensure that they release the drug(s) in a constant and

predictable manner

o A formula for tablet production

o A formally authorized Master Formula Record or Master Production

Record should exist for each product and batch size to be manufactured

▪ This document specifies the starting materials with their

quantities and packaging materials, together with a description of

the procedures and precautions required to produce a specific

quantity of a finished product as well as the processing

instructions including the in-process controls

STEP 2: Ingredients Used in Tablet Production (25 minutes)

• Tablets are composed of two main groups of ingredients;

o Active Pharmaceutical Ingredients (APIs)

▪ This is the medicament part of the tablet e.g. paracetamol,

diclofenac, amoxicillin etc.

▪ The function of API in tables is to produce pharmacological

action upon administration of the tablet

o Excipients/Pharmaceutical aids

▪ Excipients or additives are inert materials for the purpose of

improving the quality of the tablets or facilitating

manufacturing process

|Activity: Small Group Discussion ( 10 minutes) |

| |

|DIVIDE students into small manageable groups |

| |

|ASK students to discuss on the following question |

|What are the functions of excipients in tablets? |

| |

|ALLOW students to discuss for 10 minutes |

| |

|ALLOW few groups to present and the rest to add points not mentioned |

| |

|CLARIFY and SUMMARIZE by using the contents below |

• General functions of excipients are;

o Impart weight, accuracy and volume

o Ensure accuracy of the dose

o Improve solubility

o Increase stability

o Enhance bioavailability

o Modify drug release pattern

o Assist product identification

o Increase patient acceptability

o Facilitate dosage form design

STEP 5: Classification, Properties and Roles of Excipients (50 minutes)

• Classes of excipients used in the manufacture of tablets include;

o Diluents/filler/bulking agents

o Binders and adhesives

o Disintegrants

o Lubricants and glidants

o Colouring agents

o Flavouring agents

o Sweetening agents

o Adsorbent

• Diluents/filler/bulking agent

o They are fillers and make required bulk when the drug(s) is/are not

adequate to make the bulk

o They also help improve cohesion and permit use of direct compression

manufacturing or to promote flow

o Some commonly used diluents are Microcrystalline cellulose, Mannitol,

Dextrose, Sorbitol, Lactose anhydrous and Starch

o Diluents should have the following properties;

▪ Must be non toxic
▪ Must be commercially available in accepted grades
▪ Cost must be low
▪ Must be physiologically inert
▪ Must be physically and chemically stable by themselves and in

combination with the drug(s)

▪ Must be free from all microbial contamination
▪ They should not alter the bioavailability of drug
▪ They must be colour compatible
• Binders

o They are materials added to form granules or to form cohesive compacts

for directly compressed tablets

o Binders are classified into two groups

▪ Solution binders
▪ Are dissolved in solvent before being added e.g. cellulose,

gelatin

▪ Dry binders
▪ These are added to the powder blend e.g. polyethylene glycol

(PEG)

o Some commonly used binders are acacia, tragacanth, cellulose

derivatives (methyl cellulose, hydroxymethyl cellulose, hydroxyproply

cellulose), gelatine, glucose, polyvinyl pyrolidone (PVP), starch,

sodium alginate, sorbitol

• Disintegrants

o Are materials added in tablet formulation to facilitate its breaking

down when it contacts water in the gastrointestinal tract

o They are added before granulation and before compression

o Some commonly used disintegrants include starch; starch derivatives

(e.g. primogel); clays e.g. veegum, bentonite; cellulose; cellulose

derivatives e.g. sodium carboxymethyl cellulose; alginate and

polyvinyl pyrolidone cross-linked

o Super disintegrants

▪ Swell up to ten times their volume within 30 seconds of

contacting water

▪ Examples of super disintegrants include crosscarmellose (cross-

linked cellulose), crospovidone, sodium starch glycolate

• Lubricants and Glidants

o Lubricants

▪ Are substances added to reduce or prevent friction, heat and wear

when introduced as a film between solid surfaces

▪ Lubricants prevent adhesion of tablet materials to the surface of

dies and punches thereby reducing interparticle friction

▪ improve the rate of flow of granules or powder materials
▪ Commonly used lubricants are; stearic acid, stearic acid salt

(e.g. magenisum stearate), talc, polyethylene glycol (PEG),

surfactants

o Glidants

▪ Reduce friction between particles or granules and hence promote

flow

▪ Commonly used glidants are; corn starch, talc, silica derivatives

e.g. colloidal silica

• Colouring agents

o These are colours and dyes used for;

▪ Masking of off colour drugs
▪ Tablet identification
▪ Production of more elegant tablets where they impart a

distinctive appearance to the tablets

▪ Colouring agents can be natural or synthetic

o All colouring agents must be approved and certified by competent

authority e.g. TFDA

o These excipients are added in solution or in dry form

o Two classes of colouring agents are used in tablet production

▪ FD and C colours (colouring agents for foods, drugs and

cosmetics)

▪ D and C colours (colouring agents for drugs and cosmetics)

o Commonly colouring agents used in tablet production are white, sunset

yellow, tartrazine, fast green, brilliant blue, erythrosine and indigo

carmine

o Ideal characteristics of colouring agents

▪ Should be nontoxic
▪ Should not have physiological activity
▪ Should be free from harmful impurities
▪ Should have high colouring (tinctorial) power so that only small

quantities are used

▪ Should be unaffected by light, tropical temperatures, hydrolysis

and microorganisms i.e. stable on storage

▪ Should be compatible with the drugs and other excipients
▪ Should be readily soluble in water
▪ Should be free from objectionable odour or taste
▪ They should be approved and certified for use in foods, drugs and

cosmetics i.e. FD and C colouring agents

o Flavouring agents

▪ These are normally added to chewable tablets
▪ They are used to increase patient acceptance
▪ Flavour oils are used
▪ Clove oil, citric acid, rose oil, orange oil etc.

o Sweetening agents

▪ There are materials added to increase palatability
▪ They are commonly used in chewable tablets
▪ They may be natural or synthetic
▪ Commonly used sweetening agents are; saccharine (artificial)

–sweeter than sugar, has one disadvantage –bitter after taste and

carcinogenic; aspartame (artificial) –not stable in presence of

moisture

STEP 4: Key Points (5 minutes)

• Tablet formulation is the process in which the active pharmaceutical

ingredient(s) (APIs) and excipients are combined to produce a tablet

• Formulation process must ensure that the dosage form formed is stable

acceptable to the patient who will use it

• Major ingredients used in production of tablets are the active

pharmaceutical ingredient(s) and the excipients

• Excipients used in tablet manufacturing are diluents, binders and

adhesives, disintegrants, lubricants and glidants, colouring agents,

flavouring agents and sweetening agents

STEP 5: Evaluation (5 minutes)

• What is the role of glidants in tablet manufacturing?
• Who prepares the formula for tablet manufacturing?
• What are the general roles of excipients in tablet production?

References

Aulton M.E & Kevin M.G, Eds: (2013) Pharmaceutics: The design and

manufacture of medicines, (4th ed.) Churchill Livingstone

Handbook of pharmaceutical excipients, Edition sixth, Edited by Raymond

Crow, Paul J Shekey and Marian E. Quinn, Publisher –Pharmaceutical

Press

Hugo and Russell (2011), Pharmaceutical Microbiology (8th ed.), Willey-

Blackwel publications

Gennaro, R. A, et al. (Eds) (1995) Remington: The Science and Practice of

Pharmacy, Volume I & II, (19th ed.): Mack Publishing Company, Easton,

Pennsylvania 18042

Liebsch, B et al (1988): Tanzania Pharmaceutical Handbook, Dar es Salaam

University Press.

Lund, W. Editor (1994). The Pharmaceutical Codex, Principles and Practice

of Pharmaceutics (12th ed.): The Pharmaceutical Press, London

Polderman, J (1990) Introduction to Pharmaceutical Production: Novib, The

Hague

Rawlins E.A, Editor: (1977) Bentley’s Textbook of Pharmaceutics, (8th ed.)

Baillie're Tindall. London Kamm, G. and Kohler, B. Editors: (1995)

Manual for Decentralized Infusion Production, Infusion Unit Project

Tanzania

Schmidt, O. (ed) (2000) Pharmaceutical Quality systems, Interpharm Press,

Colorado.

Shayne C et al (2008), Pharmaceutical Manufacturing Handbook: Production

and processes, John Wiley & Sons

Watson, D. G (1999) Pharmaceutical Analysis: A Textbook for Pharmacy

Students and Pharmaceutical Chemists: Churchill Livingstone,

Edinburgh.

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top